LB947 An open-label study of topical ruxolitinib in necrobiosis lipoidica
نویسندگان
چکیده
Necrobiosis lipoidica (NL) is a chronic granulomatous disease of the skin. A growing body literature suggest that janus kinase (JAK) inhibitors for may be effective in treatment skin diseases, including NL. Prior translational research identified activation JAK-STAT pathways by interferon gamma (IFNγ) and other cytokines integral to macrophage these diseases. We aimed evaluate safety efficacy topical ruxolitinib, JAK-1/2 inhibitor, An open-label, single-arm study 12 patients was conducted at Mayo Clinic Arizona (NCT04492618). The primary endpoint change NL score (0-12) index lesions (weeks 0 12). Additional endpoints included: Physician Global Assessment (PGA), surface area (BSA), lesion count, Skindex-16, Pruritus NRS. Mean decreased from 4.4 (SD 1.5) baseline 1.7 1.0) week (P=0.003). Nine (81.8%) were responsive PGA 12. BSA involvement 0.4% 0.8, P=0.034). Skindex-16 improved 33.8 19.4) 11.8 13.2) (P=0.03). There no significant count or pruritus NRS This shows ruxolitinib an Larger randomized controlled trials are needed better characterize effectiveness long-term
منابع مشابه
Necrobiosis Lipoidica
Background: In 1929, Oppehhein first described necrobiosis lipoidica diabeticorum and called it dermatitis atrophicans lipoidica diabetica, but it was later renamed necrobiosis lipoidica diabeticorum (NLD) by Urbach in 1932. In 1935, Goldsmith reported the first case in a nondiabetic patient. Other cases of NLD in nondiabetic patients were described by Meischer and Leder in 1948. Rollins and Wi...
متن کاملNecrobiosis lipoidica
A 47-year-old woman reported an 18-month-old pretibial rash on her left shin during a routine office visit. She had a history of type 1 diabetes mellitus (DM) and has been on insulin therapy for the past 13 years. She did not complain of any itching, pain, or bleeding from the rash. On examination, an 8 3 cm elongated indurated plaque with telangiectases, central atrophy, and yellow pigmentatio...
متن کاملDermoscopy of Necrobiosis Lipoidica
5. Van Esso DL. Los padres frente a la vacunación. Vacunas. 2010;11:133--4. 6. Jiménez Gómez N, Ballester Martínez MA, Alcántara González J, Jaén Olasolo P. Koplik spots as a diagnostic clue in a case of measles. Med Clin (Barc). 2012;139:560. 7. Lefebvre N, Camuset G, Bui E, Christmann D, Hansmann Y. Koplik spots: a clinical sign with epidemiological implications for measles control. Dermatolo...
متن کاملNecrobiosis Lipoidica Diabeticorum
INTRODUCTION Necrobiosis lipoidica (NL) is a rare chronic granulomatous dermatitis that usually appears in the lower extremities. It affects about 0.3-1.2% of diabetic patients, the majority of whom have type 1 diabetes. The etiology and pathogenesis of this disorder are still unclear. NL is characterized by skin rash that usually affects the shins. The average onset is 30 years, with females b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Investigative Dermatology
سال: 2022
ISSN: ['1523-1747', '0022-202X']
DOI: https://doi.org/10.1016/j.jid.2022.05.966